
Metastatic Bladder Cancer — Rapid Case Review Issue 3
Oncology Today with Dr Neil Love
00:00
Sequencing: erdafitinib versus HER2 ADC
He favors erdafitinib first given randomized THOR trial evidence, reserving HER2 ADCs per smaller tumor‑agnostic data.
Play episode from 21:09
Transcript


